Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 20,127 | 24,419 | 15,360 | 13,234 | 23,014 |
| Cost of Goods | 2,499 | 2,981 | 1,481 | 1,629 | 1,367 |
| Gross Profit | 17,628 | 21,438 | 13,879 | 11,605 | 21,647 |
| Operating Expenses | 16,205 | 18,191 | 18,097 | 15,949 | 20,598 |
| Operating Income | 1,922 | 4,228 | -3,737 | -3,715 | 1,416 |
| Interest Expense | 130 | 157 | 183 | 213 | 240 |
| Other Income | 100 | 56 | 94 | 319 | 181 |
| Pre-tax Income | 1,892 | 4,127 | -3,826 | -3,609 | 1,357 |
| Income Tax | 1 | -1 | 1 | 2 | -16 |
| Net Income Continuous | 1,891 | 4,128 | -3,827 | -3,611 | 1,373 |
| Net Income | $1,891 | $4,126 | $-3,827 | $-3,611 | $1,373 |
| EPS Basic Total Ops | 0.16 | 0.32 | -0.28 | -0.28 | 0.12 |
| EPS Basic Continuous Ops | 0.14 | 0.31 | -0.29 | -0.27 | 0.11 |
| EPS Diluted Total Ops | 0.16 | 0.32 | -0.28 | -0.28 | 0.12 |
| EPS Diluted Continuous Ops | 0.14 | 0.31 | -0.29 | -0.27 | 0.10 |
| EBITDA(a) | $2,043 | $4,285 | $-3,584 | $-3,693 | $1,682 |